CureVac N.V (CVAC): Price and Financial Metrics
CVAC Price/Volume Stats
| Current price | $2.87 | 52-week high | $5.28 |
| Prev. close | $2.99 | 52-week low | $2.21 |
| Day low | $2.83 | Volume | 820,900 |
| Day high | $3.02 | Avg. volume | 820,288 |
| 50-day MA | $2.84 | Dividend yield | N/A |
| 200-day MA | $3.15 | Market Cap | 642.54M |
CVAC Stock Price Chart Interactive Chart >
CureVac N.V (CVAC) Company Bio
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee. CureVac had approximately 240 employees in November 2015 and 375 in May 2018.(Source:Wikipedia)
CVAC Price Returns
| 1-mo | 12.11% |
| 3-mo | -11.15% |
| 6-mo | -17.29% |
| 1-year | -29.31% |
| 3-year | -92.06% |
| 5-year | N/A |
| YTD | -31.83% |
| 2023 | -30.18% |
| 2022 | -82.42% |
| 2021 | -57.68% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...